Georgetown University-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2013

  1. Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-Week results of the VIKING study

    Journal of Infectious Diseases, Vol. 207, Núm. 5, pp. 740-748